Source: Annual Congress 2004 - Emphysema and oxygen therapy



Rating:

Share or cite this content

Citations should be made in the following way:
R. M. Markova (Sofia, Bulgaria). A case report of alpha 1-antitrypsin deficiency in a six-month infant. Eur Respir J 2004; 24: Suppl. 48, 1511

Member's Comments

No comment yet.

Related content which might interest you: Phase I safety investigation of an aerosolized, recombinant alpha 1-antitrypsin in subjects with alpha 1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 228s Year: 2004 COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Long-term experience in the treatment of alpha 1-antitrypsin deficiency: 25 years of augmentation therapy Source: Eur Respir Rev 2015; 24: 46-51 Year: 2015 Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm Source: Eur Respir Rev 2015; 24: 52-57 Year: 2015 Alpha 1-antitrypsin deficiency Source: Breathe 2008; 4: 377-380 Year: 2008 Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Clinical and functional characteristics of Italian and Spanish patients with alpha 1-antitrypsin deficiency Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Alpha-1 antitrypsin deficiency and spontaneous pneumothorax: just a coincidence? Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Targeted screening programmes in COPD: how to identify individuals with alpha 1-antitrypsin deficiency Source: Eur Respir Rev 2015; 24: 40-45 Year: 2015 Alpha 1 - antitrypsin deficiency: diagnosis and treatment Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment Year: 2021 Has cardiopulmonary exercise testing a role in detecting early emphysema in alpha 1-antitrypsin deficiency? Source: Eur Respir J 2001; 18: Suppl. 33, 84s Year: 2001 Does smoking impair the quality of life of 34 year olds with alpha-1 antitrypsin deficiency? Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011 Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation Source: Eur Respir J, 50 (3) 1700962; 10.1183/13993003.00962-2017 Year: 2017 What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Alpha-1-antitrypsin deficiency patients (AATD): two-year follow-up Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002